Study finds erectile dysfunction drugs linked to lower Alzheimer’s risk

Researchers evaluated the effect of phosphodiesterase-5 inhibitor (PDE5I) initiation compared to non-use and Alzheimer’s disease development risk among males suffering from erectile dysfunction.

EC approves BeiGene’s tislelizumab for three NSCLC indications – Pharmaceutical Technology

Share this article Tislelizumab is approved under the brand name Tevimbra for the treatment of unresectable or metastatic oesophageal squamous cell carcinoma (ESCC). Credits: Good

April 23, 2024

Wall Street wags say a bill to force insurers or PBMs to sell pharmacies has low odds

A proposed Senate bill that would prohibit companies that control health insurers or pharmacy benefit managers from owning pharmacies rattled investors on Wednesday, but some

December 11, 2024

Accord gears up to commercialise Hipra’s Covid-19 vaccine in the UK – Pharmaceutical Technology

The approval for Hipra’s Covid-19 vaccine was based on an immunobridging study comparing the efficacy of Bimervax with Pfizer and BioNTech’s mRNA vaccine, Comirnaty. Image

August 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.